pancreatic cancer
Showing NaN - NaN of 143
Pancreatic Cancer Trial in New York (Biopsy, FOLFIRINOX, Ciprofloxacin)
Not yet recruiting
- Pancreatic Cancer
- Biopsy
- +5 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jul 13, 2022
Pancreatic Cancer, Advanced Pancreatic Ductal Adenocarcinoma Trial in United States (Gemcitabine, Nab-paclitaxel, PEGPH20)
Active, not recruiting
- Pancreatic Cancer
- Advanced Pancreatic Ductal Adenocarcinoma
- Gemcitabine
- +2 more
-
Hartford, Connecticut
- +9 more
Jul 15, 2022
Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,
Active, not recruiting
- Breast Cancer
- +10 more
- INT230-6
- +2 more
-
Los Angeles, California
- +7 more
Jun 21, 2022
Pancreatic Cancer Trial in United States (Hypofractionated ablative IMRT (HFA-IMRT), capecitabine)
Active, not recruiting
- Pancreatic Cancer
- Hypofractionated ablative IMRT (HFA-IMRT)
- capecitabine
-
Basking Ridge, New Jersey
- +7 more
May 4, 2022
Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)
Completed
- Colorectal Cancer (CRC)
- +10 more
- Pembrolizumab
- +2 more
-
San Francisco, California
- +16 more
Mar 30, 2022
Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)
Completed
- Advanced Solid Tumors
- +6 more
- Cabiralizumab
- Nivolumab
-
Scottsdale, Arizona
- +38 more
Jan 5, 2022
Pancreatic Cancer, Pancreatic Adenocarcinoma, Pancreas Ductal Adenocarcinoma Trial in United States (Nab-paclitaxel and
Active, not recruiting
- Pancreatic Cancer
- +2 more
- Nab-paclitaxel and gemcitabine for R-PDAC Patients
- Nab-paclitaxel and gemcitabine for BR-PDAC Patients
-
Scottsdale, Arizona
- +3 more
Mar 8, 2022
Cancer of Pancreas, Cancer of the Pancreas, Tumors, Pancreatic Trial in Boston, New York (Talabostat Mesylate)
Withdrawn
- Cancer of Pancreas
- +4 more
- Talabostat Mesylate
-
Boston, Massachusetts
- +1 more
Feb 8, 2022
Advanced Solid Tumors, Solid Tumors, Ovarian Cancer Trial in Australia, United States (TALZENNA capsule, Talazoparib soft gel
Active, not recruiting
- Advanced Solid Tumors
- +7 more
- TALZENNA capsule
- Talazoparib soft gel capsule
-
Encinitas, California
- +31 more
Feb 14, 2022
Pancreatic Cancer Trial in United States (Stereotactic Body Radiotherapy (SBRT))
Active, not recruiting
- Pancreatic Cancer
- Stereotactic Body Radiotherapy (SBRT)
-
Basking Ridge, New Jersey
- +6 more
Feb 11, 2022
Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)
Terminated
- Mesothelioma
- +12 more
- MGD009
-
Los Angeles, California
- +19 more
Feb 4, 2022
Life Changes Experienced by Patients With Pancreatic Cancer
Active, not recruiting
- Pancreatic Cancer
- Measurement of Transitions in Cancer Scale (MOT-CA) Survey
- Distress Thermometer Survey
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Feb 2, 2022
Kidney Cancer, Head Neck Cancer, Breast Cancer Trial in New York (177Lu-J591)
Completed
- Kidney Cancer
- +8 more
-
New York, New YorkWeill Cornell Medical College
Feb 1, 2022
Pancreatic Cancer Trial in United States (Atezolizumab, RO7198457, mFOLFIRINOX)
Active, not recruiting
- Pancreatic Cancer
- Atezolizumab
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Jan 12, 2022
Frequency of Methods of Local Invasion of Pancreatic
Active, not recruiting
- Pancreatic Cancer
-
New York, New YorkColumbia University Irving Medical Center
Jan 5, 2022
Pancreatic Cancer Trial in United States (Whole liver irradiation (WLI), Gemcitabine and Cisplatin)
Recruiting
- Pancreatic Cancer
- Whole liver irradiation (WLI)
- Gemcitabine and Cisplatin
-
Basking Ridge, New Jersey
- +6 more
Dec 20, 2021
Pancreatic Cancer Trial in Israel, United States (Stereotactic MRI-guided On-table Adaptive Radiation Therapy)
Active, not recruiting
- Pancreatic Cancer
- Stereotactic MRI-guided On-table Adaptive Radiation Therapy
-
Los Angeles, California
- +12 more
Nov 18, 2021
Tissue & Blood From Patients w/ Benign & Malignant Tumors of
Active, not recruiting
- Esophageal Cancer
- +6 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 12, 2021
Interrogation of Exosome-mediated Intercellular Signaling in
Recruiting
- Pancreatic Cancer
- Benign Pancreatic Disease
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 11, 2021
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Recruiting
- Pancreatic Cancer
- +3 more
- Blood Draw
- +2 more
-
Middletown, New Jersey
- +12 more
Nov 10, 2021
Pancreatic Cancer Trial in New York, Seattle (Nivolumab + Cabiralizumab, Stereotactic Body Radiotherapy (SBRT))
Terminated
- Pancreatic Cancer
- Nivolumab + Cabiralizumab
- Stereotactic Body Radiotherapy (SBRT)
-
New York, New York
- +1 more
Sep 22, 2021